7 days ago
Forbes Sep 14, 2026

2026 Emmys: ‘The Pitt’s’ Noah Wyle Wins Lead Actor In A Drama Series

Noah Wyle secured his second consecutive Emmy Award for Outstanding Lead Actor in a Drama Series at the 78th Primetime Emmy Awards, held on September 14, 2026, at the Peacock Theater in Los Angeles. He was recognized for his role as Dr. Michael Robinavitch in HBO Max’s acclaimed medical drama, The Pitt, a show that honors healthcare workers and the challenges they face. This win places Wyle among a select group of actors who have won lead actor Emmys for the first two seasons of a drama series, joining names like Bryan Cranston and Bill Cosby.

In addition to his acting, Wyle is an executive producer and director on The Pitt, which has garnered widespread acclaim and a total of 25 Emmy nominations this year. The series won the Outstanding Drama Series Emmy last year and has already earned four Creative Emmy Awards in categories such as prosthetic makeup and original music. The show, created by R. Scott Gemmill and executive produced by John Wells alongside Wyle, is currently filming its third season, slated for release in January 2027 on HBO Max.

At the ceremony, Wyle expressed gratitude to his fellow nominees, with a special nod to Gary Oldman, and shared his deep passion for acting, stating that he grew up in Hollywood with a lifelong love for film and television. His dedication to authentic storytelling extends beyond the screen, as he advocates for healthcare worker support, pushing for better funding, mental health resources, fair pay, and improved legislation for frontline staff.

Wyle’s career includes multiple Emmy nominations, including for directing, and his previous nominations for his work on E.R. This recent success with The Pitt underscores both his versatility as a creator and his commitment to impactful television. The series' strong industry recognition and ongoing production highlight its status as one of the leading dramas of 2026, continuing to resonate with viewers and critics alike.

0
0 Read source
Share this post
Facebook Twitter LinkedIn

Discussion

0 comments

No comments yet

Start the discussion with a take, question, or market read.